Intelligence / Healthtech / PMA Approvals / Boston Scientific Corp
Approvalsdevice change approved (PMA)13 Sept 2026
Boston Scientific Corp
13 Sept 2026: Device change approved (PMA) · VERCISE DEEP BRAIN STIMULATION (DBS) SYSTEM. Recorded in the openFDA device PMA data.
- Decided
- 13 Sept 2026
- Device
- VERCISE DEEP BRAIN STIMULATION (DBS) SYSTEM
- Specialty
- Neurology
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Reference
- P150031 S084
- Location
- Valencia, CA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Boston Scientific Corp
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Boston Scientific Corp in our registers.
11 SeptBoston Scientific Corporationdevice cleared · HealthtechApprovals3 SeptBoston Scientificdevice cleared · HealthtechApprovals26 AugBoston Scientific Corporationdevice cleared · HealthtechApprovals21 AugBoston Scientificdevice cleared · HealthtechApprovals12 AugBoston Scientificdevice cleared · HealthtechApprovals15 OctBoston Scientific Corpdevice change approved (PMA) · HealthtechApprovals17 SeptBoston Scientificdevice change approved (PMA) · HealthtechApprovals9 SeptBoston Scientific Corpdevice change approved (PMA) · HealthtechApprovals21 AugBoston Scientific Corporationdevice change approved (PMA) · HealthtechApprovals21 OctBoston Scientific CorporationClass II recall · HealthtechQuality30 SeptBoston Scientific CorporationClass I recall · HealthtechQuality23 SeptBoston Scientific CorporationClass II recall · HealthtechQuality
More in Neurology
PMA Approvals
24 OctStryker Neurovasculardevice change approved (PMA) · Neuroform Atlas® Stent SystemApprovals23 OctCerenovus, INC.device change approved (PMA) · TRUFILL n-BCA Liquid Embolic SystemApprovals16 OctBalt USA, LLCdevice change approved (PMA) · SQUID Liquid Embolic Agent (LEA)Approvals15 OctBoston Scientific Corpdevice change approved (PMA) · Vercise DBS SystemsApprovals14 OctEv3 Neurovasculardevice change approved (PMA) · Onyx Liquid Embolic System (Onyx LES)Approvals1 OctPramand, LLCdevice change approved (PMA) · CraniSeal Dural SealantApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.